TRPC6 inhibitor (BI 764198) to reduce risk and severity of ARDS due to COVID-19: a phase II randomised controlled trial

  1. Ware, L.B.
  2. Soleymanlou, N.
  3. McAuley, D.F.
  4. Estrada, V.
  5. Diaz, G.A.
  6. Lacamera, P.
  7. Kaste, R.
  8. Choi, W.
  9. Gupta, A.
  10. Welte, T.
Aldizkaria:
Thorax

ISSN: 1468-3296,  0040-6376

Argitalpen urtea: 2023

Alea: 78

Zenbakia: 8

Orrialdeak: 816-824

Mota: Artikulua

DOI: 10.1136/THORAX-2022-219668 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus